nvs
NVS108.700USD
-1.429-1.30%
종가 05/09, 16:00（ET）시세는 15분 지연됩니다
212.97B시가총액
17.84P/E TTM
자세한 내용은 Novartis AG 회사
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
회사 정보
회사 코드NVS
회사 이름Novartis AG
상장일May 07, 2001
설립일1996
CEODr. Vasant (Vas) Narasimhan, M.D.
직원 수75883
유형Ordinary Share
회계 연도 종료May 07
주소Lichtstrasse 35
도시BASEL
증권 거래소Johannesburg Stock Exchange
국가Switzerland
우편 번호4056
전화41613241111
웹사이트https://www.novartis.com/
회사 코드NVS
상장일May 07, 2001
설립일1996
회사 임원
이름
이름/직위
직위
주식 보유
변동
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Aaron (Ronny) Gal, Ph.D.
Mr. Aaron (Ronny) Gal, Ph.D.
Chief Strategy and Growth Officer, Member of the Executive Committee
Chief Strategy and Growth Officer, Member of the Executive Committee
--
--
Mr. Victor Bulto
Mr. Victor Bulto
President - US, Member of the Executive Committee
President - US, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Ms. Karen L. Hale
Ms. Karen L. Hale
Chief Legal Officer, Member of the Executive Committee
Chief Legal Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth Mcnally
Ms. Elizabeth Mcnally
Director
Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Aaron (Ronny) Gal, Ph.D.
Mr. Aaron (Ronny) Gal, Ph.D.
Chief Strategy and Growth Officer, Member of the Executive Committee
Chief Strategy and Growth Officer, Member of the Executive Committee
--
--
Mr. Victor Bulto
Mr. Victor Bulto
President - US, Member of the Executive Committee
President - US, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Ms. Karen L. Hale
Ms. Karen L. Hale
Chief Legal Officer, Member of the Executive Committee
Chief Legal Officer, Member of the Executive Committee
--
--
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Rest of portfolio
10.07B
20.02%
Cardiovascular, Renal and Metabolism - Entresto
7.82B
15.55%
Immunology - Cosentyx
6.14B
12.20%
Neuroscience - Kesimpta
3.22B
6.41%
Oncology -Kisqali
3.03B
6.03%
Other
20.02B
39.80%
지역별USD
이름
수익
비율
United States
21.15B
42.03%
Other Foreign-
18.51B
36.79%
China
3.89B
7.73%
Germany
3.66B
7.27%
France
1.79B
3.56%
Switzerland
1.31B
2.61%
사업별
지역별
사업별USD
이름
수익
비율
Rest of portfolio
10.07B
20.02%
Cardiovascular, Renal and Metabolism - Entresto
7.82B
15.55%
Immunology - Cosentyx
6.14B
12.20%
Neuroscience - Kesimpta
3.22B
6.41%
Oncology -Kisqali
3.03B
6.03%
Other
20.02B
39.80%
주주
업데이트 시간: Wed, Apr 30
업데이트 시간: Wed, Apr 30
주주 통계
유형
주주 통계
주주
비율
Dodge & Cox
0.62%
PRIMECAP Management Company
0.53%
Dimensional Fund Advisors, L.P.
0.42%
Loomis, Sayles & Company, L.P.
0.28%
Franklin Mutual Advisers, LLC
0.22%
Other
97.93%
주주 통계
주주
비율
Dodge & Cox
0.62%
PRIMECAP Management Company
0.53%
Dimensional Fund Advisors, L.P.
0.42%
Loomis, Sayles & Company, L.P.
0.28%
Franklin Mutual Advisers, LLC
0.22%
Other
97.93%
유형
주주
비율
Investment Advisor
3.26%
Investment Advisor/Hedge Fund
2.65%
Research Firm
0.41%
Hedge Fund
0.28%
Bank and Trust
0.12%
Pension Fund
0.03%
Family Office
0.01%
Other
93.24%
기관 주식 보유
업데이트 시간: Thu, Feb 20
업데이트 시간: Thu, Feb 20
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
1921
132.66M
6.77%
-8.92M
2024Q4
1926
134.00M
6.78%
-9.24M
2024Q3
1858
134.89M
6.74%
-11.71M
2024Q2
1840
139.20M
6.87%
-9.16M
2024Q1
1808
141.30M
6.92%
-7.93M
2023Q4
1811
141.99M
6.94%
-15.97M
2023Q3
1775
150.92M
7.33%
-7.18M
2023Q2
1759
150.74M
7.28%
-24.15M
2023Q1
1762
167.49M
7.98%
-13.01M
2022Q4
1782
173.67M
8.19%
-17.15M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Dodge & Cox
12.21M
0.62%
-7.21K
-0.06%
Dec 31, 2024
PRIMECAP Management Company
11.03M
0.56%
-983.02K
-8.19%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
8.18M
0.41%
+90.82K
+1.12%
Dec 31, 2024
Loomis, Sayles & Company, L.P.
5.58M
0.28%
-192.68K
-3.34%
Dec 31, 2024
Franklin Mutual Advisers, LLC
4.26M
0.22%
-16.98K
-0.40%
Dec 31, 2024
Wellington Management Company, LLP
3.65M
0.18%
-351.31K
-8.78%
Dec 31, 2024
Morgan Stanley Smith Barney LLC
3.59M
0.18%
-52.88K
-1.45%
Dec 31, 2024
Parametric Portfolio Associates LLC
2.98M
0.15%
-86.17K
-2.81%
Dec 31, 2024
Managed Account Advisors LLC
2.95M
0.15%
-214.17K
-6.76%
Dec 31, 2024
Renaissance Technologies LLC
2.67M
0.14%
+368.17K
+16.00%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
VanEck Pharmaceutical ETF
5.37%
Amplify International Enhanced Dividend Income ETF
3.22%
Altrius Global Dividend ETF
2.54%
Invesco International Dividend Achievers ETF
2.2%
Pacer Global Cash Cows Dividend ETF
2.2%
The Opal International Dividend Income ETF
1.89%
SP Funds S&P World (ex-US) ETF
1.89%
Avantis International Large Cap Value ETF
1.75%
Brandes International ETF
1.74%
SGI Enhanced Global Income ETF
1.64%
더 보기
VanEck Pharmaceutical ETF
비율5.37%
Amplify International Enhanced Dividend Income ETF
비율3.22%
Altrius Global Dividend ETF
비율2.54%
Invesco International Dividend Achievers ETF
비율2.2%
Pacer Global Cash Cows Dividend ETF
비율2.2%
The Opal International Dividend Income ETF
비율1.89%
SP Funds S&P World (ex-US) ETF
비율1.89%
Avantis International Large Cap Value ETF
비율1.75%
Brandes International ETF
비율1.74%
SGI Enhanced Global Income ETF
비율1.64%
주식 배당금
지난 5년 동안 총
36.74B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 20, 2025
NVS.NB Approximate final Cash Dividend of gross USD 3.869541 going ex on Mar 12, 2025
Mar 12, 2025
May 01, 2025
Mar 12, 2025
Feb 12, 2024
NVS.NB Final Cash Dividend of gross USD 3.739544 paid on Apr 19, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Apr 19, 2024
Mar 07, 2024
Feb 02, 2023
NVS.NB Final Cash Dividend of gross USD 3.498699 paid on Mar 20, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 20, 2023
Mar 09, 2023
Feb 04, 2022
NVS.NB Final Cash Dividend of gross USD 3.32525 paid on Mar 17, 2022 going ex on Mar 08, 2022
Mar 09, 2022
Mar 17, 2022
Mar 08, 2022
Jan 26, 2021
NVS.NB Final Cash Dividend of gross USD 3.199072 paid on Mar 15, 2021 going ex on Mar 04, 2021
Mar 05, 2021
Mar 15, 2021
Mar 04, 2021
Jan 31, 2020
NVS.NB Final Cash Dividend of gross USD 3.087366 paid on Mar 12, 2020 going ex on Mar 03, 2020
Mar 04, 2020
Mar 12, 2020
Mar 03, 2020
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음